Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the macugen market grown over the years?

The market size for macugen has seen a XX (HCAGR) trend in the past few years. The market, previously worth $XX million in 2024, is projected to expand to $XX million in 2025, growing at a compound annual growth rate (CAGR) of XX%. Factors contributing to this growth during the historic period include a surge in the aged population, enhanced patient awareness, increased healthcare expenditure, a rise in research and development initiatives, and an expansion of emerging markets.

What Is the forecasted market size and growth rate for the macugen market?

In the coming years, it’s projected that the Macugen market will experience XX (FCAGR), leading to a valuation of $XX million by 2029 with an XX% compound annual growth rate. Key factors fueling this growth within the prediction timeframe include amplified diagnosis and treatment rates, proliferation of wet AMD, escalating instances of AMD, boosted investment in healthcare infrastructure, and growing awareness about diabetic eye conditions. Key trends observed during the prediction period encompass an inclination towards combination therapies, improvements in drug delivery systems, mechanical innovations in the field of ophthalmology, growth in diagnostic methodology, and the development of enhanced treatments for AMD.

Get your macugen market report here!

https://www.thebusinessresearchcompany.com/report/macugen–global-market-report

What are the major factors driving growth in the macugen market?

The anticipated rise in the number of age-related macular degeneration (AMD) cases is projected to drive the growth of the macugen market. AMD is an eye condition that progresses with age, affecting the macula which is the central part of the retina responsible for clear and detailed vision. The increased prevalence of AMD can be linked to a global aging population, longer life expectancy, as well as lifestyle habits such as smoking, poor diet, and extended exposure to ultraviolet light. Macugen is a beneficial treatment for AMD, inhibiting vascular endothelial growth factor (VEGF), which reduces abnormal growth and leakage of blood vessels in the retina, and aids in preserving vision and delaying disease progression. For example, a report published by the National Center for Biotechnology Information, a US-based National Institutes of Health government agency, in May 2023, predicts that about 288 million people will be affected by AMD by 2040. Thus, the surge in AMD cases is playing a key role in boosting the macugen market.

What key areas define the segmentation of the global macugen Market?

The macugen market covered in this report is segmented –

1) By Indication: Wet AMD(Age-Related Macular Degeneration (AMD)); Diabetic Macular Edema

2) By Formulation: Intravitreal Injection; Extended-Release Formulations

3) By Distribution Channel: Hospitals And Clinics; Retail And Specialty Pharmacies

4) By End User: Adult Patients; Geriatric Patients

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20440&type=smp

What are the top market players propelling the growth of the macugen industry?

Major companies operating in the macugen market are Bausch + Lomb Inc

What are the key trends shaping the future of the macugen market?

The primary movement in the macugen market is the advancement of gene therapy. Gene therapy is a technique that includes infusing genetic materials into a patient’s cells with the aim to treat or ward off diseases, specifically honing in on age-related macular degeneration (AMD). An example of this is when Regenxbio, a biotechnology firm based in the U.S., in 2023, introduced RGX-314, a distinctive gene therapy solution designed to directly release a gene that encodes an anti-VEGF protein into the eye. This ground-breaking therapy seeks to extend its effects by reducing the dependency on regular injections. Noteworthy aspects of RGX-314 encompass its potential for a one-time administration, a feature that could dramatically better patient adherence, and its capability to address the root causes of AMD instead of merely controlling symptoms. These progressions place companies in an advantageous position within the dynamic terrain of ocular treatments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20440

What regions are dominating the macugen market growth?

North America was the largest region in the macugen market in 2024. The regions covered in the macugen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Vitreoretinal Surgery Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/vitreoretinal-surgery-devices-global-market-report

Retinal Biologics Global Market Report 2025

https://thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Retinal Disorder Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: